Stereoretentive Catalytic Olefin Metathesis. In Situ Methylene Capping
07. August, 2017In situ methylene capping: A general strategy for efficient stereoretentive catalytic olefin metathesis is developed using Ru dithiolate catalysts. The concept, methodological implications, and applications to synthesis of biologically active compounds is described.
Read moreStereoselective Catalytic Cross-Metathesis
15. June, 2017Unsaturated organoboron compounds are important reagents in organic synthesis e.g. (pinacolato)allylboron [allyl-B(pin)] are involved in many stereoselective additions while (pinacolato)vinylboron [alkenyl-B(pin)] reagents are used in various catalytic cross coupling reactions.
Read moreCatalytic Ring-Closing Metathesis
02. May, 2017Catalytic RCM has played a prominent role in connection with the synthesis of macrocyclic alkenes, a structural motif found in an array of biologically active molecules. There is a high demand to develop catalysts that reliably deliver kinetic control of stereoselectivity in the formation of large-ring olefins.
Read moreActivation of Oxo Tungsten Complexes
12. April, 2017The coordination of B(C6F5)3to an oxo ligand in tungsten oxo alkylidene bis(aryloxide) complexes, where the aryloxide is O-2,6-(mesityl) 2C6H3 (HMTO) or 2,6-diadamantyl-4-methylphenoxide (dAdPO), accelerates the formation of metallacyclobutane complexes from alkylidenes as well as the rearrangement of metallacyclobutane complexes.
Read moreRing-Opening Metathesis Polymerization
30. March, 2017It has been shown that Z-selective reactions in ROMP have some generality and that syndiotacticity (for cis polymers) is predictable as a consequence of the mechanism through which MAP catalysts operate, i.e., inversion of configuration at the metal center with each forward metathesis step (stereogenic metal control).
Read moreCategories
Contact
XiMo AG (Headquarter)
Altsagenstrasse 3
CH-6048 Horw/Lucerne
Switzerland
www.ximo-inc.com
Mel Luetkens, CEO
Georg Fráter, COO
XiMo Hungary Ltd.,
Graphisoft Park 'DB' Bdg.
Záhony u. 7.
H-1031 Budapest
Levente Ondi, R&D Director,